2 insiders reported 2 Form 4 transactions for Veraxa Biotech AG - Post de-SPAC (VRXA) over the past 18 months (most recent 2026-08-31). Recent activity: Antz Christoph Rudiger (Chief Executive Officer) Buy 5,000 shares, Baumann Oliver Rolf (Director) Buy 50,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Antz Christoph Rudiger | Chief Executive Officer | Buy | 5,000 | $7,650 |
| 2026-08-31 | Baumann Oliver Rolf | Director | Buy | 50,000 | $75,000 |
来源：SEC Form 4 申报文件 · 截至 2026-08-31